Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.64M Sell
16,645
-63
-0.4% -$10.2K 0.2% 87
2025
Q1
$2.34M Buy
16,708
+948
+6% +$154K 0.15% 119
2024
Q4
$2.63M Buy
15,760
+521
+3% +$92.5K 0.16% 105
2024
Q3
$2.6M Buy
15,239
+2,190
+17% +$317K 0.17% 100
2024
Q2
$1.84M Buy
13,049
+1,010
+8% +$125K 0.13% 122
2024
Q1
$1.51M Buy
12,039
+1,314
+12% +$150K 0.11% 139
2023
Q4
$1.13M Buy
10,725
+1,468
+16% +$160K 0.09% 150
2023
Q3
$981K Buy
9,257
+380
+4% +$44K 0.09% 153
2023
Q2
$1.06M Buy
8,877
+391
+5% +$40.4K 0.11% 131
2023
Q1
$789K Buy
8,486
+1,201
+16% +$105K 0.09% 153
2022
Q4
$596K Buy
7,285
+990
+16% +$75.2K 0.07% 171
2022
Q3
$384K Sell
6,295
-989
-14% -$72.4K 0.05% 217
2022
Q2
$509K Sell
7,284
-110
-1% -$8.05K 0.07% 176
2022
Q1
$612K Buy
7,394
+3,222
+77% +$261K 0.06% 183
2021
Q4
$364K Buy
4,172
+538
+15% +$50.5K 0.04% 231
2021
Q3
$317K Buy
+3,634
New +$321K 0.04% 213

Other funds holding ORCL

Graypoint LLC's ORCL Position: Q2 2025 in Review

Graypoint LLC reduced its Oracle (ORCL) stake by 0.38% in Q2 2025, selling an estimated $10.2K and leaving 16,645 shares worth $3.64M. The position accounts for 0.2% of the portfolio, ranked #87.

Graypoint LLC first reported a position in ORCL in Q3 2021 and has held it in 16 quarters since. 3,616 funds tracked by Wall St. Rank hold ORCL as of Q2 2025.

  • Graypoint LLC held 16,645 shares of Oracle worth $3.64M as of Q2 2025.
  • Graypoint LLC sold 63 Oracle shares in Q2 2025, an estimated $10.2K.
  • Oracle made up 0.2% of Graypoint LLC's portfolio in Q2 2025, its #87 holding.
  • Graypoint LLC first reported a position in Oracle in Q3 2021 and has held it in 16 quarters since.
  • 3,616 funds tracked by Wall St. Rank held Oracle as of Q2 2025.

Based on Graypoint LLC's 13F filing for Q2 2025, filed 15 Jul 2025.